aamc.org does not support this web browser. Learn more about the browsers we support.

New section

Content Background

New section

AAMC Submits Comments to HHS on Regulatory Relief During COVID-19

January 8, 2021

New section

New section

CONTACTS
Gayle Lee, Director, Physician Payment & Quality

The AAMC submitted comments on Dec. 24 to the Department of Health and Human Services (HHS) on a request for information about regulatory relief to support economic recovery during the COVID-19 pandemic.

In the comments, the AAMC stated that it was “grateful that HHS and its associated agencies and institutes have continued to be a partner with the AAMC and our member institutions and appreciate the tremendous efforts made to quickly evaluate opportunities for flexibilities from current policies to ensure providers can deliver quality care for all patients during the public health emergency (PHE).”

The AAMC included specific comments on selected regulatory changes implemented by the Centers for Medicare and Medicaid Services, the Office of Civil Rights, the Food and Drug Administration, and the National Institutes of Health. For each regulatory waiver or flexibility, the comments expressed whether AAMC supported making it permanent.  For some of the policies, in the comments, AAMC requested a one-year extension beyond the end of the PHE to allow for adequate time to change workflows and re-educate providers, researchers, and others.

New section

New section